Chatbot aims to help teens with cancer risk genes make better health decisions
NCT ID NCT04323774
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 26 times
Summary
This study is testing a tool called AYA-RISE, which includes a chatbot and an online portal, to help teenagers and young adults (ages 12-24) who have genetic conditions that raise their cancer risk. The goal is to see if the tool helps them better understand their cancer risk, talk about it with their families, and make informed decisions about screening and care. About 115 participants will use the tool, and researchers will measure how useful and acceptable it is.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER RISK SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Boston Children's Hospital
Boston, Massachusetts, 02115, United States
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02115, United States
-
Emory University School of Medicine
Atlanta, Georgia, 30342, United States
-
University of Chicago
Chicago, Illinois, 60637, United States
-
University of Utah, Huntsman Cancer Institute
Salt Lake City, Utah, 84112, United States
Conditions
Explore the condition pages connected to this study.